FIELD: medicine, oncology, pharmacy. SUBSTANCE: invention relates to use of acyl derivatives of aromatic aldehydes for treatment of cancer patients. Proposed compounds inhibit protein synthesis in anomal cells. EFFECT: enhanced effectiveness of treatment. 7 cl, 12 dwg, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOESTER COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2139884C1 |
| NUCLEOSIDE ESTERS AND PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2126417C1 |
| DERIVATIVES OF ARABINOFURANOSYLCYTOSINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1996 |
|
RU2165260C2 |
| IMMUNOTHERAPEUTIC IMIDES/AMIDES AS INHIBITORS OF PHOSPHODI-ESTERASE-IV (PDE-IV) AND TUMOR NECROSIS FACTOR (TNF) | 1997 |
|
RU2177471C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2525392C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2466729C2 |
| IMIDE/AMIDE ETHERS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF FNOK LEVEL IN MAMMALIAN | 1995 |
|
RU2164514C2 |
| DERIVATIVES OF HEMCYTABINE | 1998 |
|
RU2194711C2 |
| SINGLE-CHEMICAL NUCLEIC ACID MOLECULES FOR GENE EXPRESSION CONTROL | 2011 |
|
RU2628311C2 |
| NOVEL AMPHYL DERIVATIVES OF ALFA-C-PHENYL-N-TRET-BUTYLNITRONE | 2003 |
|
RU2364602C2 |
